# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-049114
Filing Date
2024-04-26
Accepted
2024-04-26 16:09:42
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | apls-_2024_-_ars.pdf | ARS | 2902891
| Complete submission text file | 0000950170-24-049114.txt |  | 3999741

Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38276 | Film No.: 24883729
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)